Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 80.63M | £ 29.65M | £ 23.18M | £ 25.06M | £ 41.38M |
Total Assets | £ 516.90M | £ 465.79M | £ 421.36M | £ 462.66M | £ 430.72M |
Total Debt | £ 100.23M | £ 99.98M | £ 101.02M | £ 96.47M | £ 87.51M |
Net Debt | £ 19.59M | £ 70.33M | £ 77.84M | £ 71.42M | £ 46.13M |
Total Liabilities | £ 306.79M | £ 260.21M | £ 217.50M | £ 250.29M | £ 214.71M |
Stockholders Equity | £ 210.12M | £ 206.48M | £ 204.45M | £ 212.82M | £ 216.44M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |